Price movement over the last 24 hours
Agilent Technologies Inc vs Duolingo Inc — how do they compare? Agilent Technologies Inc trades at $128.2 (market cap $37.04B), while Duolingo Inc trades at $128.31 (market cap $6.15B). The key difference: Agilent Technologies Inc is far larger — about 6× Duolingo Inc's market cap, and Agilent Technologies Inc pays a 0.78% dividend while Duolingo Inc pays none. Which is the better fit depends on your goals.
| A | DUOL | |
|---|---|---|
Market Cap | $37.04B | $6.15B |
Sector | Health | Technology |
52-Week High | $157.20 | $390.84 |
52-Week Low | $110.24 | $90.03 |
Enterprise Value | $38.59B | $4.99B |
Dividend Yield | 0.78% | — |
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
Duolingo (DUOL) trades at $131.95, up 4.92% with strong technical momentum and bullish moving average signals. The company demonstrates exceptional fundamental strength with 2025 revenue reaching $1.04 billion and net income of $414 million, representing a 38.4% margin. Recent earnings beats and expanding profitability highlight operational excellence amid AI-driven product expansion into math and music learning.
Outlook remains positive with projected 2026 revenue growth to $1.1 billion, though the stock trades above analyst consensus target of $110.20. Key risks include competitive pressure in edtech and valuation concerns with P/E of 14.8 and P/S of 5.7. Institutional sentiment leans cautious with 59% hold ratings despite strong fundamentals.
Trailing returns across standard periods
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →Duolingo Inc is a mobile learning platform to learn languages and the top-grossing app in the Education category on both Google Play and the Apple App Store. It has three predominant sources of revenue
Read more on DUOL →